Changing Reimbursement for Clinical Pathology Laboratory Testing and Direct-to-Consumer Testing Discussed at California Clinical Laboratory Association Conference in San Diego
The end of fee-for-service payments has huge implications for U.S. medical laboratories and anatomic pathology practices
SAN DIEGO, CALIFORNIA—In the American healthcare system today, the era of fee-for-service medicine will soon end. This development has huge implications for every clinical laboratory and anatomic pathology practice in the United States because fee-for-service is their primary source of revenue.
This week at the 2013 Annual Conference of the California Clinical Laboratory Association (CCLA), no single topic got more attention than that of reimbursement for clinical laboratory tests and anatomic pathology services. (more…)